Evidence map›Paper›PMID 40018685›Full record

ArticleFrontiers in psychiatry2025

Impact of life adversity and gene expression on psychiatric symptoms in children and adolescents: findings from the Brazilian high risk cohort study.

Vanessa Kiyomi Ota, Adrielle Martins Oliveira, Amanda Victória Gomes Bugiga, Helena B Conceição, Pedro Alexandre Favoretto Galante, Paula Fontes Asprino, Julia Luiza Schäfer, Mauricio Scopel Hoffmann, Rodrigo Bressan, Elisa Brietzke and 10 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Vanessa Kiyomi OtaLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Adrielle Martins OliveiraLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Amanda Victória Gomes BugigaLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Helena B ConceiçãoCentro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil.
Pedro Alexandre Favoretto GalanteCentro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil.
Paula Fontes AsprinoCentro de Oncologia Molecular, Hospital Sírio-Libanês, São Paulo, Brazil.
Julia Luiza SchäferNational Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health (CISM), Porto Alegre, Brazil.
Mauricio Scopel HoffmannNational Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health (CISM), Porto Alegre, Brazil.
Rodrigo BressanLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Elisa BrietzkeDepartment of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada.
Gisele Gus ManfroNational Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health (CISM), Porto Alegre, Brazil.
Rodrigo Grassi-OliveiraTranslational Neuropsychiatry Unit, Aarhus University, Aarhus, Denmark.
Ary GadelhaLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Luis Augusto RohdeNational Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health (CISM), Porto Alegre, Brazil.
Euripedes Constantino MiguelNational Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health (CISM), Sao Paulo, Brazil.
Pedro Mario PanLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Marcos Leite SantoroLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Giovanni Abrahao SalumNational Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health (CISM), Porto Alegre, Brazil.
Carolina Muniz CarvalhoLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
Sintia Iole BelangeroLaboratory of Integrative Neuroscience (LiNC), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.

Funding

Reproducible imaging-based brain growth charts for psychiatryR01MH120482 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI MILHAM, MICHAEL PETER, SATTERTHWAITE, THEODORE · 2019 to 2023
$3.5M
NIMH NIH HHS R01 MH120482
6 · The paper itself

Abstract

Introduction: While the influence of both genetic and environmental factors on the development of psychiatric symptoms is well-recognized, the precise nature of their interaction throughout development remains a subject of ongoing debate. This study investigated the association between the expression of 78 candidate genes, previously associated with psychiatric phenotypes, in peripheral blood and both adversity and psychopathology in a sample of 298 young individuals assessed at two time points from the Brazilian High Risk Cohort Study for Mental Conditions (BHRCS). Methods: Psychopathology was assessed using the Child Behavior Checklist (CBCL), considering the total CBCL, p-factor (i.e. general factor of psychopathology), and internalizing and externalizing symptoms as clinical variables. The life adversities considered in this study includes four composite variables: child maltreatment, stressful life events, threat and deprivation. Gene expression was measured using next-generation sequencing for target genes and differential gene expression was analyzed with the DESeq2 package. Results: Mixed models revealed six genes associated with internalizing symptoms: NR3C1, HSPBP1, SIN3A, SMAD4, and CRLF3 genes exhibited a negative correlation with these symptoms, while FAR1 gene showed a positive correlation. Additionally, we also found a negative association between USP38 gene expression and externalizing symptoms. Finally, DENND11 and PRRC1 genes were negatively associated with deprivation, a latent factor characterized by neglect, parental absence, and measures of material forms of deprivation. No mediation or moderation effect was observed of gene expression on the association between life adversities and psychiatric symptoms, meaning that they might influence distinct pathways. Discussion: Among these nine genes, NR3C1, which encodes a glucocorticoid receptor, is by far the most investigated, being associated with depressive symptoms, early life adversity, and stress. While further research is needed to fully understand the complex relationship between gene expression, life adversities, and psychopathology, our findings provide valuable insights into the molecular mechanisms underlying mental disorders.

Indexed as

externalizing symptomsgeneticsinternalizing symptomspsychopathologytranscriptometrauma

Identifiers

PMID40018685
PMCPMC11866055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.